Blue Cross Blue Shield · Coverage Exception · US health-plan appeal rights

Coverage Exception denied as not FDA-approved for this use by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield Coverage Exception denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for coverage exception are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: BCBS Compounded Drug Coverage Policy (varies by state plan)

The Blue Cross Blue Shield angle on Coverage Exception

## Why BCBS Denied Your Coverage Exception as Not FDA-Approved

A not-FDA-approved denial means BCBS determined that the requested treatment either lacks FDA approval for the indication you are seeking it for, or does not meet its policy standards for coverage of unapproved uses. This type of denial is distinct from an experimental denial, though the two often overlap: a treatment may have FDA approval for one condition but be used "off-label" for another, or it may be in the pre-approval pipeline.

These denials are appealable, particularly in two scenarios: (1) the treatment actually does carry FDA approval for your indication and the denial reflects a documentation or classification error, and (2) the treatment is used off-label but is supported by sufficient evidence and applicable clinical guidelines that BCBS's own policy may cover.

## Your Federal Appeal Rights

Internal appeal (ACA §2719 / ERISA §503): You have the right to a written internal appeal. The timeframe is stated in your denial letter — commonly 180 days.
External review: After a final internal denial, an independent review organization (IRO) evaluates the determination. The external-review request window is generally up to approximately four months. IRO decisions are binding on the plan.
Expedited review: If your health would be seriously jeopardized by delay, you may request expedited review, with internal decisions typically required within 72 hours.

## How to Build Your Appeal

1. Confirm and document FDA status for your exact indication. Obtain the FDA-approved prescribing label for the treatment. Confirm whether your indication falls within the approved labeling. If it does, flag this directly in your appeal — the denial may be a classification error. If it is an off-label use, note that clearly and shift your argument to evidence-based off-label coverage.

2. Check BCBS's policy on off-label coverage. Many BCBS plans have explicit policies covering off-label use when it is supported by peer-reviewed evidence and recognized clinical compendia. Request the applicable policy and use its own criteria to build your argument.

3. Gather a prescriber letter that addresses the approval question directly. The letter should: confirm the clinical indication; explain whether the use is on-label or off-label; cite applicable clinical guidelines by organization; and document why this treatment is medically necessary for your specific case.

4. Document clinical severity and treatment history. Include diagnosis confirmation, objective findings supporting severity, prior treatment attempts with dates and outcomes, and why alternatives are insufficient.

5. Use the criteria-mapping structure. Copy the specific requirements from BCBS's policy and answer each with chart-based facts.

## Timeline

File the internal appeal within the window shown on your denial letter.
After a final internal denial, file for external review within approximately four months.

DenialHelp can help you map the FDA approval question against BCBS's own policy criteria and draft a structured appeal letter.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield Coverage Exception

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.